India to Sudan: Ceftriaxone Export Trade Route
India has recorded 268 verified shipments of Ceftriaxone exported to Sudan, representing a combined trade value of $10.3M USD. This corridor is served by 39 active Indian exporters, with an average shipment value of $38.4K USD. The leading Indian exporter is SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, which accounts for 21% of total export value with 74 shipments worth $2.2M USD. On the buying side, TO THE ORDER is the largest importer in Sudan with $1.2M USD in purchases. The top 3 suppliers — SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, M/S PHARMAFLUENT, INNOVA CAPTAB LIMITED — together control 43% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Sudan Ceftriaxone corridor is one of India's established pharmaceutical export routes, with 268 shipments documented worth a combined $10.3M USD. The route is dominated by SCOTT-EDIL ADVANCE RESEARCH LABORATORIES & EDUCATI, which alone accounts for roughly 21% of all export value, reflecting the consolidated nature of India's ceftriaxone manufacturing sector.
Across 39 active suppliers, the average shipment value stands at $38.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with ceftriaxone's non-urgent bulk-order profile.
Shipment activity peaks during July-September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 29.2%, placing it at rank #15 among India's top ceftriaxone export destinations globally.
On the import side, key buyers of Indian ceftriaxone in Sudan include TO THE ORDER, TO THE ORDER OF, ELWALIEF INTERNATIONAL FOR MULTI AC and 49 others. TO THE ORDER is the single largest importer with 24 shipments valued at $1.2M USD.
